Article
Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.
Mammalian genome : official journal of the International Mammalian Genome Society - 1 Feb 2016
Qi Xuchen, Wan Yingfeng, Zhan Qitao, Yang Shuxu, Wang Yirong, Cai Xiujun
Abstract excerpt
So far, epidemiological studies have been performed to investigate the association of CDKN2A/B rs4977756 polymorphism and glioma risk. However, the results from different studies remain inconsistent. To clarify these conflicts and to quantitatively evaluate the effect of rs4977756 polymorphism on glioma risk, a meta-analysis was conducted using relevant published clinical studies about rs4977756 polymorphisms and...
Read the complete abstract on PubMed